International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: V. Treatment strategies in panic disorder, 1992-1997

Journal of Clinical Psychopharmacology

Volumn 18, Issue 6 SUPPL. 2, 1998, Pages

  Uhlenhuth, E H ^a   Balter, Mitchell B ^b   Ban, Thomas A ^c   Yang, Kenneth ^d  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Systems Concept Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ADULT; ANXIETY NEUROSIS; CASE REPORT; COGNITION; CONFERENCE PAPER; EXPERT SYSTEM; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; PANIC; PEER REVIEW; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; TREATMENT INDICATION;

ADULT; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; BENZODIAZEPINES; CHRONIC DISEASE; COGNITIVE THERAPY; FEMALE; HEALTH SURVEYS; HUMANS; PANIC DISORDER; QUESTIONNAIRES;

EID: 0031789688     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (12)

1. Klein DF. Clinical psychopharmacologic practice: the need for developing a research base. Arch Gen Psychiatry 1993;50: 491-4.
2. Balter MB, Ban TA, Uhlenhuth EH. International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications. I. Current concerns. Human Psychopharmacol 1993;8:253-61.
3. Uhlenhuth EH, Balter MB, Ban TA, Yang K. International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications. II. Pharmacotherapy of anxiety disorders. J Affect Disord 1995;35:153-62.
4. Uhlenhuth EH, Balter MB, Ban TA, Yang K. International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications. III. Clinical features affecting experts' therapeutic recommendations in anxiety disorders. Psychopharmacol Bull 1995;31:289-96.
5. Aronson TA. A naturalistic study of imipramine in panic disorder and agoraphobia Am J Psychiatry 1987;144:1014-9.
6. Mavissakalian MR, Perel JM. Imipramine treatment of panic disorder with agoraphobia: dose ranging and plasma level-response relationships. Am J Psychiatry 1995;152:673-82.
7. Pohl R, Yeragani VK, Balon R, Lycaki H. The jitteriness syndrome in panic disorder patients treated with antidepressants. J Clin Psychiatry 1988;49:100-4.
8. Uhlenhuth EH, Matuzas W, Glass RM, Easton C. Response of panic disorder to fixed doses of alprazolam or imipramine. J Affect Disord 1989;17:261-70.
9. Lopes CS, Rodrigues LC, Sichieri R. The lack of selection bias in a snowball sampled case-control study on drug abuse. Int J Epidemiol 1996;25:1267-70.
10. Michielutte R, Beal P. Identification of community leadership in the development of public health education programs. J Commun Health 1990:15:59-68.
11. Thompson SK. Adaptive sampling in behavioral surveys. NIDA Res Monogr 1997;167:296-319.
12. Van Meter KM. Methodological and design issues: techniques for assessing the representativeness of snowball samples. NIDA Res Monogr 1990;98:31-43.